DOC Pharma: A New Identity for the Generic Drugs Company, Advancing Growth By Targeting Broader Pharmaceutical Market
Veröffentlicht: 07.08.2025 um 18:06 Uhr, prnewswire.co.uk
DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the previously announced acquisition of Muscoril®New brand identity reflects the Company's vision for growthView original content to download multimedia:https://www.prnewswire.co.uk/news-releases/doc-pharma-a-new-identity-for-the-generic-drugs-company-advancing-growth-by-targeting-broader-pharmaceutical-market-302374695.html
en | boerse | 67950272 |
